
    
      This study will determine the rate of all pneumothoraces and those pneumothoraces requiring
      treatment following percutaneous lung biopsy in patients who have received ABPI or BioSentry
      at the end of the biopsy procedure. The data collected will be used to determine if there is
      equal effectiveness in the reduction of pneumothorax rates from both interventions.
    
  